abrdn Healthcare Investors

HQH

Market cap $1.07B

Always build your portfolio around your unique lifestyle goals—don't end up standing on a beach in snow pants. Mimicking ultra-wealthy founders is dangerous. Billionaires have completely different financial goals, skills, and timelines than retirees. Warren Buffett's empire relies on controlling operating companies and a massive Treasury bill hoard, not simple stock-picking.

abrdn Healthcare Investors offers diversified healthcare exposure with a high yield, but structural inefficiencies persist. HQH trades near its narrowest historical discount to NAV, making current valuation less attractive versus its five-year average. The fund's high payout relies on net realized gains, risking NAV erosion and inconsistent dividend coverage during sector downturns.

PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on May 29, 2026 to all shareholders of record as of May 21, 2026 (ex-dividend date May 21, 2026). The abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), and the India Fund, Inc. (IFN) will pay their distributions on June 30, 2026, to shareholders of record as of May 21, 2026 (ex‑dividend date May 21, 2026).

Variable policies prevent funds from over-distributing and eroding the long-term capital base. HQH: Secure a 3% quarterly payout from the cutting edge of biotech and pharmaceutical innovation. USA: Get broad, large-cap exposure while maintaining a double-digit yield through five elite management teams.

Investors have thousands of choices. Your preferences matter, and knowing what you want sharpens your decision-making. Income-focused discipline creates real clarity and confidence.

PHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on March 31, 2026, on a per share basis to all shareholders of record as of March 24, 2026 (ex-dividend date March 24, 2026). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and Aberdeen India Fund Inc. (IFN) which paid on March 31, 2026, to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026).

Healthcare dividend stocks are selling off with the turbulence in the Middle East.

abrdn Healthcare Investors offers more volatile healthcare exposure, leaning heavily toward biotech, making it riskier than traditional healthcare funds. HQH's 12% managed distribution policy yields high distribution, but sustainability depends on capital gains in a cyclical, boom-bust biotech sub-sector. The fund's discount has narrowed since our last write-up, reducing its relative attractiveness versus historical averages, but it has continued to deliver strong recent performance.

Outsource the Expertise: Don't waste time mastering biotech or commercial debt; use the specialized skills of institutional managers at abrdn Healthcare Investors and Apollo Commercial Real Estate Finance to do it for you. 11.1% Yield in Healthcare: Capitalize on the aging U.S. demographic with HQH, which just declared its highest quarterly dividend since 2015. Ride along with ARI as they convert their $9B loan portfolio into a massive cash pile to hunt for high-return M&A opportunities.

PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, FCO, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026).